Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iryna Horak"'
Autor:
Anna Grebinyk, Svitlana Prylutska, Sergii Grebinyk, Maxim Evstigneev, Iryna Krysiuk, Tetiana Skaterna, Iryna Horak, Yanfang Sun, Liudmyla Drobot, Olga Matyshevska, Yuriy Prylutskyy, Uwe Ritter, Marcus Frohme
Publikováno v:
Cancer Nanotechnology, Vol 12, Iss 1, Pp 1-18 (2021)
Abstract Background Berberine (Ber) is a herbal alkaloid with pharmacological activity in general and a high anticancer potency in particular. However, due to its low bioavailability, the difficulty in reaching a target and choosing the right dose, t
Externí odkaz:
https://doaj.org/article/515fc86442e74979a9d1b62bac126f2b
Autor:
Yanfang Sun, Xiaoyan Gao, Pan Wang, Michael Wink, Liudmyla Drobot, Xiaoyan Jin, Iryna Horak, Jinhua Li, Linjun Yang, Zongsuo Liang
The authors have requested that this preprint be removed from Research Square.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46f265b03594be7a0a08fb77ea406755
https://doi.org/10.21203/rs.3.rs-1264811/v1
https://doi.org/10.21203/rs.3.rs-1264811/v1
Autor:
Lulu Dian, Zhaozhen Xu, Yanfang Sun, Jinhua Li, Hongfei Lu, Meng Zheng, Juan Wang, Liudmyla Drobot, Iryna Horak
Publikováno v:
Phytochemistry. 200
Berberine alkaloids belong to the class of isoquinoline alkaloids that have been shown to possess anticancer potential, berberine exhibits inhibitory effects on breast cancer development. However, the exact mechanisms of action for anti-breast carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd89e5d2de689ec320df9592f8d847c1
https://pubmed.ncbi.nlm.nih.gov/35504329
https://pubmed.ncbi.nlm.nih.gov/35504329
Autor:
A.G. Naumovets, Uwe Ritter, I. I. Grynyuk, Anna Grebinyk, T. D. Skaterna, Marcus Frohme, A. Senenko, Svitlana Prylutska, O. P. Matyshevska, Iryna Horak, Liudmyla Drobot, Yuriy Prylutskyy
Publikováno v:
Archives of Toxicology. 93:1213-1226
Cisplatin (Cis-Pt) is the cytotoxic agent widely used against tumors of various origin, but its therapeutic efficiency is substantially limited by a non-selective effect and high toxicity. Conjugation of Cis-Pt with nanocarriers is thought to be one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4c446dfb1963ff9b0cec023533e2689
https://doi.org/10.1007/s00204-019-02441-6
https://doi.org/10.1007/s00204-019-02441-6
Autor:
Iryna Horak, Jacek Piosik, Maxim P. Evstigneev, Yuriy Prylutskyy, Liudmyla Drobot, O. P. Matyshevska, Svitlana Prylutska, Iryna Krysiuk, Franskevych Dv, Uwe Ritter, Dmytro Rumiantsev, Serhii Luhovskyi, A. Senenko, Nina Tverdokhleb, Oleksii Hrabovsky
Publikováno v:
Materials
Volume 14
Issue 20
Materials, Vol 14, Iss 6114, p 6114 (2021)
Volume 14
Issue 20
Materials, Vol 14, Iss 6114, p 6114 (2021)
Effective targeting of metastasis is considered the main problem in cancer therapy. The development of herbal alkaloid Berberine (Ber)-based anticancer drugs is limited due to Ber’ low effective concentration, poor membrane permeability, and short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3a939193b067e5a2ef4c2d4d673dba
https://doi.org/10.3390/ma14206114
https://doi.org/10.3390/ma14206114
Autor:
Svitlana, Prylutska, Iryna, Grynyuk, Tetiana, Skaterna, Iryna, Horak, Anna, Grebinyk, Liudmyla, Drobot, Olga, Matyshevska, Anton, Senenko, Yuriy, Prylutskyy, Anton, Naumovets, Uwe, Ritter, Marcus, Frohme
Publikováno v:
Archives of toxicology. 93(5)
Cisplatin (Cis-Pt) is the cytotoxic agent widely used against tumors of various origin, but its therapeutic efficiency is substantially limited by a non-selective effect and high toxicity. Conjugation of Cis-Pt with nanocarriers is thought to be one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdfcd25063c864bfe52c6387c3000a43
https://pubmed.ncbi.nlm.nih.gov/30989314
https://pubmed.ncbi.nlm.nih.gov/30989314